Patients with IBS symptoms, bloating, food sensitivities, chronic inflammation, or post-antibiotic gut damage are common candidates for peptide therapy gut protocols
The key mechanical difference from BPC-157 is that TB-500 does not need to be injected near the injury
The in vitro data demonstrated that AOD9604 increases 3-AR expression in fat cells, contributing to enhanced lipolytic sensitivity
$600,000) per Fiscal Year
Growth Hormone Axis Signals Some preclinical data suggest BPC-157 may interact with growth hormone secretagogue receptors or downstream IGF-1 signaling, though the evidence is less consistent than for the dopamine and NO pathways
investigational, with no approved human indication